首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats
【2h】

Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats

机译:EDHF参与大鼠PAR-2激活引起的低血压和胃粘膜血流量增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Agonists for protease-activated receptor-2 (PAR-2) cause hypotension and an increase in gastric mucosal blood flow (GMBF) in vivo. We thus studied the mechanisms underlying the circulatory modulation by PAR-2 activation in vivo, especially with respect to involvement of endothelium-derived hyperpolarizing factor (EDHF).Arterial blood pressure and GMBF were measured in anesthetized rats in vivo. Vascular relaxation was assessed in the precontracted rat gastric arterial rings in vitro.The PAR-2-activating peptide SLIGRL-NH2 and/or trypsin, administered i.v., produced largely NO-independent hypotension and increase in GMBF accompanied by decreased gastric mucosal vascular resistance (GMVR) in rats.Combined administration of apamin and charybdotoxin, but not each of them, specifically abolished the hypotension, increased GMBF and decreased GMVR caused by the PAR-2 agonists.In the isolated rat gastric artery, SLIGRL-NH2 elicited endothelium-dependent relaxation even in the presence of an NO synthase inhibitor and indomethacin, which was abolished by apamin plus charybdotoxin.Our data suggest involvement of apamin/charybdotoxin-sensitive K+ channels in the PAR-2-triggered hypotension and increased GMBF, predicting a role of EDHF-like factors.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 蛋白酶激活受体2(PAR-2)的激动剂在体内引起低血压和胃粘膜血流量(GMBF)的增加。因此,我们研究了体内PAR-2激活对循环调节的潜在机制,特别是在涉及内皮源超极化因子(EDHF)方面。 在麻醉的大鼠中测量动脉血压和GMBF。体内。体外评估了预收缩大鼠胃动脉环中的血管舒张情况。 静脉内施用的PAR-2激活肽SLIGRL-NH2和/或胰蛋白酶产生了与NO无关的低血压,并伴有GMBF升高通过减少大鼠胃粘膜血管阻力(GMVR)来达到目的。 联合应用apamin和charybdotoxin,但并非每种都可以特异性地消除由PAR-2激动剂引起的低血压,GMBF升高和GMVR降低。 即使在存在NO合酶抑制剂和吲哚美辛的情况下,SLIGRL-NH2也会在离体的大鼠胃动脉中引起内皮依赖性舒张,而阿帕明加Charybdotoxin消除了吲哚美辛。 数据表明,对apa-2-触发的低血压和GMBF升高,涉及到对apapa / chd的毒素敏感的K + 通道,并预测GMBF升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号